NO864741D0 - Amorfe, ikke-krystallinske former av terapeutisk virksomme benzimidazolderivater. - Google Patents

Amorfe, ikke-krystallinske former av terapeutisk virksomme benzimidazolderivater.

Info

Publication number
NO864741D0
NO864741D0 NO864741A NO864741A NO864741D0 NO 864741 D0 NO864741 D0 NO 864741D0 NO 864741 A NO864741 A NO 864741A NO 864741 A NO864741 A NO 864741A NO 864741 D0 NO864741 D0 NO 864741D0
Authority
NO
Norway
Prior art keywords
crystallinic
amorph
forms
therapeutically effective
benzimidazold
Prior art date
Application number
NO864741A
Other languages
English (en)
Inventor
Richard Allen Runkel
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO864741D0 publication Critical patent/NO864741D0/no
Priority to NO874739A priority Critical patent/NO874739D0/no
Priority to NO881788A priority patent/NO881788D0/no
Priority to NO881787A priority patent/NO881787D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • C07D235/32Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO864741A 1985-11-27 1986-11-26 Amorfe, ikke-krystallinske former av terapeutisk virksomme benzimidazolderivater. NO864741D0 (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO874739A NO874739D0 (no) 1985-11-27 1987-11-13 Fremgangsmaate for fremstilling av amorfe benzimidazolderivater med forbedret opploeselighet og anthelmintisk aktivitet.
NO881788A NO881788D0 (no) 1985-11-27 1988-04-22 Fremgangsmaate for fremtilling av amorfe benzimidazolderivater med forbedret opploeselighet og anthelmintisk aktivitet
NO881787A NO881787D0 (no) 1985-11-27 1988-04-22 Fremgangsmaate for femstilling av amorfe benzimidazolderivater med fobedret opploeselighet og anthelmintisk aktivitet.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80279885A 1985-11-27 1985-11-27

Publications (1)

Publication Number Publication Date
NO864741D0 true NO864741D0 (no) 1986-11-26

Family

ID=25184726

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864741A NO864741D0 (no) 1985-11-27 1986-11-26 Amorfe, ikke-krystallinske former av terapeutisk virksomme benzimidazolderivater.

Country Status (11)

Country Link
EP (1) EP0224249A1 (no)
JP (1) JPS62155263A (no)
KR (1) KR870004967A (no)
AU (1) AU6569886A (no)
DK (1) DK569786A (no)
FI (1) FI864812A (no)
HU (1) HUT43575A (no)
IL (1) IL80767A0 (no)
NO (1) NO864741D0 (no)
PT (1) PT83812B (no)
ZA (1) ZA868963B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5419897A (en) * 1993-04-09 1995-05-30 Buckman Laboratories International, Inc. Ionene polymers as anthelmintics in animals
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
ATE313952T1 (de) * 1999-06-04 2006-01-15 Nufarm Ltd Stabile biozidale zusammensetzung
EP2596792A1 (en) * 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations
JP2006513159A (ja) 2002-11-01 2006-04-20 メルク エンド カムパニー インコーポレーテッド アンドロゲン受容体モジュレーターとしてのカルボニルアミノ−ベンズイミダゾール誘導体
US9095585B2 (en) 2011-07-21 2015-08-04 Bristol-Myers Squibb Company Bioavailable compositions of amorphous piperidinyl compounds
EA202192753A1 (ru) 2019-04-11 2022-01-11 Бристол-Маерс Сквибб Компани Повышенная эффективность аморфных твердых и солюбилизированных составов для достижения терапевтических концентраций в плазме

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601101A (ja) * 1983-06-15 1985-01-07 Yuukou Yakuhin Kogyo Kk 水性懸濁農薬製剤
DE3347579A1 (de) * 1983-12-30 1985-07-11 Hoechst Ag, 6230 Frankfurt Zubereitungen schwer wasserloeslicher anthelminthika und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS62155263A (ja) 1987-07-10
HUT43575A (en) 1987-11-30
ZA868963B (en) 1988-07-27
AU6569886A (en) 1987-06-04
FI864812A (fi) 1987-05-28
PT83812A (en) 1986-12-01
PT83812B (en) 1988-03-15
EP0224249A1 (en) 1987-06-03
IL80767A0 (en) 1987-02-27
DK569786D0 (da) 1986-11-26
DK569786A (da) 1987-05-28
FI864812A0 (fi) 1986-11-26
KR870004967A (ko) 1987-06-02

Similar Documents

Publication Publication Date Title
DE3766958D1 (de) Isochinolin-derivate.
ATE49403T1 (de) N-aralkylpiperidinmethanol-derivate.
FI874671A0 (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
FI854035L (fi) Farmaceutiska foereningar med antracyklinglykosider.
DE3675232D1 (de) Pyridinderivate.
DE3678805D1 (de) Indolderivate.
NO864110D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
DE3684549D1 (de) Carboxamidderivate.
FI860209A (fi) Engaongselektrod foer undersoekning av en patient.
DE3680067D1 (de) Fluorphenylcyclohexanderivate.
ATE41655T1 (de) Phenaethanolaminderivate.
NO864741D0 (no) Amorfe, ikke-krystallinske former av terapeutisk virksomme benzimidazolderivater.
FI853938A0 (fi) Anordning foer profilmaetning av raelshjul.
DE3576066D1 (de) Isochinolinderivate.
DE3682446D1 (de) Isochinolinderivate.
FI860247A (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
FI852706L (fi) Skiktade kirurgiska utensilier av kompoundstruktur.
NO864818D0 (no) Fremgangsmaate for fremstilling av nye terapeutisk virksomme tetrahydroisokinolinderivater.
MX9203229A (es) Derivados de lankacidina.
NO864740D0 (no) Amorfe, ikke-krystallinske former av terapeutisk virksomme benzimidazolderivater.
FI863883A0 (fi) Anordning foer tillslutning av flaskhals.
DE3689338D1 (de) Isocarbacyclinderivate.
FI860911A0 (fi) Anordning foer reglering av roekgasernas utloppshastighet i en skorsten.
NO853525L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
FI864736A0 (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.